SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-015517
Filing Date
2024-01-25
Accepted
2024-01-25 17:01:29
Documents
13
Period of Report
2024-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d707707d8k.htm   iXBRL 8-K 28494
2 EX-10.1 d707707dex101.htm EX-10.1 1457051
  Complete submission text file 0001193125-24-015517.txt   1945561

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20240119.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20240119_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20240119_pre.xml EX-101.PRE 11692
7 EXTRACTED XBRL INSTANCE DOCUMENT d707707d8k_htm.xml XML 3529
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 24563065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)